Trial Profile
A multicenter, randomized, active-controlled comparison study of the incidence of gastroduodenal ulcers associated with celecoxib and low dose ASA [aspirin] versus naproxen and low dose ASA in healthy subjects (50-75 years of age)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Aspirin; Naproxen
- Indications Ankylosing spondylitis; Gouty arthritis; Juvenile rheumatoid arthritis; Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis; Thrombosis
- Focus Adverse reactions
- Sponsors Viatris Inc
- 06 Nov 2005 New trial record.